Cyclacel Pharmaceuticals (Cyclacel Pharmaceuticals) Current Accrued Expense : $4.24 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Cyclacel Pharmaceuticals Current Accrued Expense?

Cyclacel Pharmaceuticals's Current Accrued Expense for the quarter that ended in Dec. 2023 was $4.24 Mil.

Cyclacel Pharmaceuticals's quarterly Current Accrued Expense increased from Jun. 2023 ($4.34 Mil) to Sep. 2023 ($6.22 Mil) but then declined from Sep. 2023 ($6.22 Mil) to Dec. 2023 ($4.24 Mil).

Cyclacel Pharmaceuticals's annual Current Accrued Expense increased from Dec. 2021 ($2.54 Mil) to Dec. 2022 ($3.94 Mil) and increased from Dec. 2022 ($3.94 Mil) to Dec. 2023 ($4.24 Mil).

Cyclacel Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for Cyclacel Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclacel Pharmaceuticals Current Accrued Expense Chart

Cyclacel Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

0.85

1.11

2.54

3.94

4.24

Cyclacel Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															3.94	4.61	4.34	6.22	4.24

Cyclacel Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Cyclacel Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cyclacel Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclacel Pharmaceuticals (Cyclacel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (NAS:CYCCP.PFD) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CYCC:USA UXI:Germany

Address

200 Connell Drive, Suite 1500, Berkeley Heights, NJ, USA, 07922

Website

https://www.cyclacel.com

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.